October 4th 2025
Artificial intelligence, machine learning, and novel instruments are helping drug developers evaluate complex data from bioanalytical studies.
In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
September 29th 2025
In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
September 23rd 2025
Advances in digital technologies offer effective data handling for bio/pharma manufacturing.
September 22nd 2025
In a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The Role of Statistical Significance Tests
Gamma Irradiation in the Pharmaceutical Manufacturing Environment
The author reviews the benefits, challenges, and considerations to be made when selecting a gamma-irradiation sterilization method.
Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing
The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes. This article is part of a special issue on Bioprocessing and Sterile Manufacturing.
An Overview of Rapid Microbial-Detection Methods
Pharmaceutical Technology talked to drugmakers, equipment vendors, and service providers to learn more about the advantages and disadvantages of rapid microbial-detection methods.
Integrated Microfluidic LC-MS
The authors describe a new microfluidic-based workflow that integrates and automates glycan cleaveage, purification, and chromatographic separation onto a microfluidic liquid chromatography–mass spectrometry chip for MS detection.
The Myth Called "Sterility"
The authors propose a process-centric approach for carrying out aseptic-processing and suggest further dialogue. This articles contains bonus online-exclusive material.
Week Of Feb. 22, 2010: Company And People Notes: Merck To Eliminate 15,000 Jobs; Tauzin Stepping Down At PhRMA; And More.
Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.
Week Of Feb. 15, 2010: Company And People Notes: Abbott Completes Acquisition Of Solvay; Merck Names President Of Consumer Healthcare; And More.
Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.
February 2010 Editor's Picks: Products from ABB and David Round
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the February 2010 edition from ABB and David Round.
Week Of Feb. 8, 2010: Company And People Notes: VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.
VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.
Week of Feb. 1, 2010: Company and People Notes: Cephalon Buys Mepha; BASi's CEO Retires; and More.
Cephalon Buys Mepha; BASi's CEO Retires; and More.
Do Visible Residue Limits Make the 10-ppm Carryover Limit Obsolete?
The author discusses how the use of a visible residue limit has made the 10-ppm cleaning limit obsolete in many applications.
The Talk of the Lab
Sharing too much-or too little-information can have disastrous onsequences.
Is the Internet to Blame for Unsafe Drug Use?
FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies.
In the Spotlight February 2010
Editors' Picks of Pharmaceutical Science & Technology Innovations
Breaking Down Barriers to Oral Delivery
A recent book provides information about formulating biopharmaceuticals that is easy to swallow.
In the Field: Report from Europe
Regulators and industry move to require inspections of API manufacturing facilities.
Innovation Today, Rewards Tomorrow
When it comes to healthcare rform, we must not overlook investment in innovative technologies.
Implications and Opportunities of Applying QbD Principles to Analytical Measurements
The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods. This article contain bonus online material.
PAT: A New Dawn for Drug Product Quality
Leading experts share insight on the current and future direction of process analytical technology. This article contains bonus online material.
Multivariate data analysis easily retrieves insight from a wealth of data
Statistics are often viewed as confusing and complicated, but multivariate data analysis (MVA) methods can be used to amass knowledge simply.
Week Of Jan. 25, 2010: Company And People Notes: Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.
Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.
Week Of Jan. 18, 2010: Company And People Notes: FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility; And More.
FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility.
USP Recalls Latest Monographs
The United States Pharmacopeial Convention is recalling USP 33?NF 28.
Week of Jan. 4, 2010: Company And People Notes: Bioject Medical Technologies establishes alliance with MPI Research; Biogen Idec CEO to retire; And More.
Bioject Medical Technologies establishes alliance with MPI Research; Biogen Idec CEO to retire; And More.
Understanding Biological Indicator Grow-Out Times
This study used biological indicators containing Geobacillus stearothermophilus spores and a new technology to continuously monitor incubated BIs and record nonsterile results.
A Mass Transfer of Knowledge
A comprehensive book about mass transfer benefits from the author's personal touch.
FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 1: Drug Substance
Team leaders in FDA's Office of Generic Drugs provide an overview.
AAI Pharma's Lee Karras talks about contract-service demand.
Plus, novel dosage forms and emerging trends.
A PAT Solution for Automated Mill Control
The authors describe the implementation of an on-line particle-size analyzer on an active pharmaceutical ingredient milling operation at a commercial site.